Imperial academics have received funding from the National Institute of Health Research (NIHR) to support new research on long-term COVID. Three Imperial projects are among 15 UK-based studies supported by.
China Oncology Focus, a subsidiary of Lee's Pharm, has enrolled the first patient in the double-blind Phase 3 trial of Socazolimab in combination with chemotherapy as the first-line treatment of.
Overview Memorial Sloan Kettering scientists explore ways to develop effective CAR T Cell Therapies for solid tumors. Results from a clinical trial in people with mesothelioma indicate that an experimental.
Image: A histological picture of cancerous breast tissue. Credit: Dr Cecil Fox, National Cancer Institute A blood test to watch breast cancer's "molecular clock" could help track the growth of.
Amgen received FDA approval earlier this year for a drug that targets a rare mutation once considered "non-medicinal." Frontier Medicines is going after the same mutation, but the biotech believes.
Giants in the drug industry are betting billions on one of the most popular targets in cancer research. Researchers hope that drugs targeting a protein called TIGIT could open up.